2023 HFSA Annual Scientific Meeting OnDemand

Educational Activity

The 2023 HFSA Annual Scientific Meeting OnDemand contains recordings of scientific sessions held during the HFSA Annual Scientific Meeting 2023. Learners can view recorded presentations to enhance their knowledge and learn the latest in heart failure care, treatment, research, and more. Continuing education credits are available for this product.


This educational activity is designed for HFSA’s Annual Scientific Meeting is intended for physicians, nurses, nurse practitioners, pharmacists, scientists, and health care professionals who specialize or have an interest in heart failure.


Original recording Date: October 6-9, 2023

Expiration Date: November 19, 2024


Member's Rate: $499/Non-Member's Rate: $599


Educational Content included in the Annual Scientific Meeting OnDemand


1st Annual HFSA Case Competition


Advances in Cardio-Oncology


Approach to Suspected HFpEF Evaluation in 2023


Artificial Intelligence & Machine

Learning: The Future is Now or Later?


Cardiogenic Shock Management


Caring for the Pregnant Patient with Heart Failure


Challenges in Diagnosis and

Management of Cardiac Amyloidosis


Contemporary Management of Cardiac Sarcoidosis


Current Electrophysiology Perspectives in LVAD Patients


Device Innovation to Manage Congestion in Heart Failure





Electrophysiology Considerations in Heart Failure


Engaging Cardiovascular Team Clinicians in Clinical Trial Research and Quality Improvement


FDA Special Session: Subgroups and Subpopulations in HF Clinical Trials


Frontiers in Surveillance of the Transplanted Heart: What Lies Beneath


Great Debates in Heart Failure


Heart Failure Editor’s Forum: Journal Visions, Multi-Disciplinary Efforts, Top Science and Role in Increasing HF Clinicians


HFpEF Mechanisms of Disease: New Insights and Therapeutic Implications


HFSA Spotlight: Rapid Fire Abstracts: Emerging Heart Failure Therapies


Hot Topics in HF: Management of Anemia and Iron Deficiency


Jay N. Cohn (JNC) New Investigator Award Presentations



Managing Congestion: Targeting Pressure vs Volume


Monday Plenary Session: HFSA Spotlight on Featured Clinical Science


New Paradigms of Care in Hypertrophic Cardiomyopathy


Novel Implementation Strategies and How-to


Nursing New Investigator Award


Practical Implementation of Guideline-Directed Medical Therapy in Heart Failure


Presidential Plenary Session


Pulmonary Hypertension and RV Failure in Advanced Heart Failure


Remote Care in Heart Failure Post Pandemic


Structural Interventions for Heart Failure: Challenges and Controversies








Sunday Plenary Session: HFSA Spotlight on Late Breaking ClinicalTrials


Targeting Obesity to Treat Heart Failure


The Future of the Machines


The Heart Allocation System in the United States


The Importance of Implementation


The State of the Specialty Town Hall


Value Based Payment & the Business of Heart Failure


What You Need to Know in 30 Minutes: Frailty Assessment and Cardiac Rehabilitation in Patients with HF


What You Need to Know in 30 Minutes: Sleep Apnea in Heart Failure


What You Need to Know in 30 Minutes: Urine Sodium to Manage Acute Heart Failure





Following this educational activity, attendees will be able to:


  • Describe the epidemiology of HF and implement strategies for the prevention of HF.
  • Discuss the current scientific basis of HF from the perspectives of cardiovascular physiology, neurohormones, tissue factors, molecular biology, and genetics.
  • Identify the findings of basic science research and current clinical trials and describe their implications for current and future HF therapy.
  • Implement optimal guideline-based therapeutic options for HF, including pharmacologic agents, non-pharmacologic options, such as diet and exercise, and implantable devices.
  • Manage comorbidities including hypertension, diabetes, depression, sleep apnea, and chemotherapy.
  • Demonstrate awareness of psychosocial, economic, regulatory, and ethical issues in the treatment of patients with HF.
    Explain the patient, provider and system-related factors that contribute to racial and ethnic health disparities.
  • Implement strategies for effective management of the patient with HF, incorporating the family, encouraging self- care, and employing the team approach.
  • Outline strategies for transitioning patients from impatient to outpatient care and for reducing hospital readmissions.
  • Engage in performance measurement and other site-based research.




Credits Available

CME 47.25; CNE:47.25 (including nursing pharmacology of 13.00)

CPE: 27.5

MOC: 7.75

Powered by Oasis.